Literature DB >> 15379735

Enhancing enhancers: new complexities in the retinoid regulation of gene expression.

Chris P F Redfern1.   

Abstract

Retinoic acid is a signalling molecule central to morphogenesis and musculoskeletal development. It can exist in several isomeric forms, of which all-trans- and 9-cis-retinoic acid are thought to be the most relevant as signalling molecules. Retinoic acid regulates gene expression via RARs (retinoic acid receptors) working as heterodimers with RXRs (retinoid X receptors). RXRs also heterodimerize with other nuclear receptors. In this issue of the Biochemical Journal, Harris et al. have shown that an enhancer responsible for chondrocyte-specific expression of the col11a2 gene is itself regulated by a retinoic-acid-dependent interaction with RXRbeta bound to a downstream response element. Thus, RXRs bound to hormone-response elements can regulate gene expression indirectly via interactions with tissue-specific enhancers. This study raises interesting questions about the nature of the response element, the RXRbeta partner and the ligands able to influence col11a2 expression, and will provide a model system with which to understand tissue and ligand specificity of retinoid responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15379735      PMCID: PMC1134059          DOI: 10.1042/BJ20041277

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

1.  RXR beta isoforms in neuroblastoma cells and evidence for a novel 3'-end transcript.

Authors:  B Rana; A D Pearson; C P Redfern
Journal:  FEBS Lett       Date:  2001-09-28       Impact factor: 4.124

Review 2.  Retinoic acid and chick limb bud development.

Authors:  C Tickle
Journal:  Dev Suppl       Date:  1991

Review 3.  The RXR heterodimers and orphan receptors.

Authors:  D J Mangelsdorf; R M Evans
Journal:  Cell       Date:  1995-12-15       Impact factor: 41.582

4.  Polyunsaturated fatty acids including docosahexaenoic and arachidonic acid bind to the retinoid X receptor alpha ligand-binding domain.

Authors:  Johan Lengqvist; Alexander Mata De Urquiza; Ann-Charlotte Bergman; Timothy M Willson; Jan Sjövall; Thomas Perlmann; William J Griffiths
Journal:  Mol Cell Proteomics       Date:  2004-04-08       Impact factor: 5.911

5.  Isomerization of all-trans-retinoic acid to 9-cis-retinoic acid.

Authors:  J Urbach; R R Rando
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

Review 6.  LXRs; oxysterol-activated nuclear receptors that regulate genes controlling lipid homeostasis.

Authors:  Peter A Edwards; Matthew A Kennedy; Puiying A Mak
Journal:  Vascul Pharmacol       Date:  2002-04       Impact factor: 5.773

7.  A novel retinoic acid-response element requires an enhancer element mediator for transcriptional activation.

Authors:  Laura R Harris; Olli-Pekka Kamarainen; Minna Sevakivi; Gwen C Miller; James W Clarke; Jennifer L Potter; Laura C Bridgewater
Journal:  Biochem J       Date:  2004-10-01       Impact factor: 3.857

8.  Induction of lysosomal phospholipase A2 through the retinoid X receptor in THP-1 cells.

Authors:  Akira Abe; Heather K Poucher; Miki Hiraoka; James A Shayman
Journal:  J Lipid Res       Date:  2004-02-01       Impact factor: 5.922

Review 9.  Nuclear retinoid receptors and the transcription of retinoid-target genes.

Authors:  Julie Bastien; Cécile Rochette-Egly
Journal:  Gene       Date:  2004-03-17       Impact factor: 3.688

Review 10.  Revisiting the role of retinoid signaling in skeletal development.

Authors:  Andrea D Weston; Lisa M Hoffman; T Michael Underhill
Journal:  Birth Defects Res C Embryo Today       Date:  2003-05
View more
  1 in total

Review 1.  SOX Transcription Factors as Important Regulators of Neuronal and Glial Differentiation During Nervous System Development and Adult Neurogenesis.

Authors:  Milena Stevanovic; Danijela Drakulic; Andrijana Lazic; Danijela Stanisavljevic Ninkovic; Marija Schwirtlich; Marija Mojsin
Journal:  Front Mol Neurosci       Date:  2021-03-31       Impact factor: 5.639

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.